Sunday, July 26, 2026 | 01:30 AM ISTहिंदी में पढें
Page 5 - Biocon Stock
Biocon: Street to keep an eye on CY21 launches, market share gains
Launch of a cancer drug was delayed due to Covid-19
 "Biocon: Street to keep an eye on CY21 launches, market share gains")
Updated On : 29 Dec 2020 | 12:27 AM IST
Biocon dips 11% in three days on disappointing September quarter results
The company said profitability was impacted on account of higher R&D expenses, staff costs, other expenses and forex losses
 "Biocon dips 11% in three days on disappointing September quarter results")
Updated On : 26 Oct 2020 | 2:58 PM IST
Multiple growth levers for Biocon; ramp-up, new biosimilars to boost profit
Ramp-up and new biosimilars should help boost profit
 "Multiple growth levers for Biocon; ramp-up, new biosimilars to boost profit")
Updated On : 29 Jan 2020 | 11:26 PM IST
Biocon stock: Rich valuations, regulatory news flow may add to volatility
Analysts expect Biocon to gain 20-25 per cent market share and after factoring in a 20-25 per cent price erosion in the first year, they see its earnings improving to Rs 12-16
 "Biocon stock: Rich valuations, regulatory news flow may add to volatility")
Updated On : 06 Jun 2018 | 7:04 AM IST